You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API CEPHALEXIN


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing CEPHALEXIN

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 CARBOXYMETHYLCELLULOSE SODIUM
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 CELLULOSE, MICROCRYSTALLINE
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 D&C YELLOW NO. 10
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 DIMETHICONE
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 FD&C BLUE NO. 1
Fera Pharmaceuticals LLC CEPHALEXIN cephalexin 48102-021 FD&C YELLOW NO. 6
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing CEPHALEXIN

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 MAGNESIUM STEARATE
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 POLYETHYLENE GLYCOL 400
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 POLYETHYLENE GLYCOL 8000
Teva Pharmaceuticals USA Inc cephalexin 0093-2238 POLYSORBATE 80
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for CEPHALEXIN

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: BENZYL ALCOHOL

Excipient focus: BLUE 1

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CI 15985

Excipient focus: CI 42090

Excipient focus: CI 47005

Excipient focus: CI 77891

Excipient focus: CITRIC ACID

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C GREEN NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE BLACK

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: METHYLCELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYSORBATE 80

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SACCHARIN SODIUM

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: STARCH, CORN

Excipient focus: STRAWBERRY

Excipient focus: SUCROSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Excipient focus: YELLOW 10

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links